54025 A Maximum-Use Trial of Ruxolitinib Cream in Children ≥2 to <12 Years Old with Atopic Dermatitis (AD): Patient-Reported Outcomes (PROs) at Week 8

Authors

Andrea Zaenglein MD

Publication/Presentation Date

9-2024

Volume

91

Issue

3

First Page

106

Last Page

106

Published In/Presented At

https://doi.org/10.1016/j.jaad.2024.07.426

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine Faculty

Document Type

Article